Hyperglycemia-induced thrombin formation in diabetes: The possible role of oxidative stress

Diabetes

Volumn 44, Issue 8, 1995, Pages 924-928

  Ceriello, Antonio ^a,b   Giacomello, Roberta ^b   Stel, Giuliana ^b   Motz, Enrico ^a   Taboga, Claudio ^c   Tonutti, Laura ^c   Pirisi, Mario ^a   Falleti, Edmondo ^b   Bartoli, Ettore ^a  

^a Chair of Internal Medicine ^*  (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCOAGULABILITY; HYPERGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOGENESIS;

EID: 0029131083     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.44.8.924     Document Type: Article

References (23)

1. Ostermann H, van de Loo J: Factors of the hemostatic system in diabetic patients: a survey of controlled studies. Haemostasis 16:386-416, 1986
2. Ceriello A: Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 36:1119-1125, 1993
3. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
4. Ceriello A, Giugliano D: Oxidative stress and diabetic complications. In International Textbook of Diabetes Mellitus. 2nd ed. Alberti KGMM, Zimmet P, DeFronzo RS, Eds. New York, Wiley. In press
5. Ceriello A, Quatraro A, Giugliano D: New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabetic Med 9:297-299, 1992
6. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Lefebvre PJ: Metabolic control may influence the increased superoxide anion generation in diabetic serum. Diabetic Med 8:540-542, 1991
7. Barrowcliffe TW, Gutteridge JM, Gray E: Oxygen radicals, lipid peroxidation and the coagulation system. Agent Actions 22:347-348, 1987
8. Rabie MI, Blashill A, Furie BC: Prothrombin fragment 1.2.3, a major product of prothrombin activation in human plasma. J Biol Chem 261:13210-13215, 1986
9. Ceriello A, Giacomello R, Colatutto A, Taboga C, Gonano F: Increased prothrombin fragment 1+2 in type I diabetic patients. Haemostasis 22:50-51, 1992
10. Assereto SAR, Lauterburg BH: High-dose intravenous glutathione in man: pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest 21:103-110, 1991
11. Pelzer H, Schwarz A, Stuber W: Determination of human prothrombin activation F1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemostasis 65:153-159, 1991
12. Jones RL: Fibrinopeptide A in diabetes mellitus: relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes. Diabetes 34:836-841, 1985
13. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Marchi E, Torella R: Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism 38:1162-1163, 1989
14. Jones RL, Peterson CM: Reduced fibrinogen survival in diabetes mellitus: a reversible phenomenon. J Clin Invest 63:485-493, 1979
15. Ceriello A, Giugliano D, Quatraro A, Dello Russo P, Torella R: Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 31:889-891, 1988
16. Collier A, Rumley AG, Paterson JR, Leach JP, Lowe GDO, Small M: Free radical activity and hemostatic factor in NIDDM patients with and without microalbuminuria. Diabetes 41:909-913, 1992
17. Knöbl P, Schernthaner G, Schack C, Pietschnann P, Griesmacher A, Prager R, Müller M: Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1045-1050, 1993
18. Boeri D, Almus FE, Maiello M, Cagliero E, Rao LVM, Lorenzi M: Modification of tissue-factor mRNA and protein response to thrombin and interleukin 1 by high glucose in cultured human endothelial cells. Diabetes 38:212-218, 1989
19. Bohlen HG, Lash JM: Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol 265:H219-H225, 1993
20. Nemerson Y: Tissue factor and hemostasis. Blood 71:1-8, 1988
21. Vanhoutte PM: Endothelium and control of vascular function: state of the art lecture. Hypertension 13:658-667, 1989
22. Tesfamariam B: Free radicals in diabetic endothelial cell dysfunction. Free Radical Biol & Med 16:383-391, 1994
23. Curcio F, Ceriello A: Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanism of diabetic vascular complications. In Vitro Cell Dev Biol 28A:787-790, 1992